Koligo Therapeutics Ltd
Biotechnology company · Sydney, New South Wales, Australia
Koligo Therapeutics Ltd is a biotechnology company headquartered in Sydney, New South Wales, Australia. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $38,000 sold in a notice filed in 2019.
Koligo Therapeutics at a glance
What does Koligo Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $38,000 sold (2019).
Frequently asked questions about Koligo Therapeutics
Where is Koligo Therapeutics headquartered?
Koligo Therapeutics Ltd is headquartered in Sydney, New South Wales, Australia.
What does Koligo Therapeutics do?
Koligo Therapeutics Ltd is a biotechnology company.
When was Koligo Therapeutics founded?
The earliest incorporation on record for Koligo Therapeutics Ltd is in 2018, according to public company registers.
Similar companies
- AdvanCell Isotopes Pty LtdSydney, New South Wales, Australia
- Azure Health Technology LtdSydney, New South Wales, Australia
- Mesoblast LtdMelbourne, Victoria, Australia
- Opthea LtdSouth Yarra, Victoria, Australia
- Island Pharmaceuticals LtdCamberwell, Victoria, Australia
- Medical Developments InternationalScoresby, Victoria, Australia
- Acrux DDS Pty LtdWest Melbourne, Victoria, Australia
- EnGeneIC LtdNorthwood, New South Wales, Australia
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences